Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antiproliferative agents from Pfizer

Feb. 19, 1997

Sugen continues to focus on TK inhibitors

Feb. 19, 1997

Aphton and Pasteur Merieux Connaught form immunotherapy product alliance

Feb. 18, 1997

AEterna clarifies Neovastat clinical development program

Feb. 18, 1997

Mechanism of antitumor effect of natural lipopolysaccharide

Feb. 18, 1997

Progen's lead compound shows promise for cancer/metastasis

Feb. 18, 1997

Apoptosis-regulating factor discovered

Feb. 17, 1997

Chiron prepares uPA inhibitors

Feb. 17, 1997

Human Genome Sciences discloses novel human polypeptide for cancer

Feb. 17, 1997

BASF focuses on dolastatin derivatives

Feb. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...